GO
| HSI1 | 24,788.14 | +37.35 | 255.76B |
| HSCEI1 | 8,374.30 | -24.82 | 90.75B |
| Back Zoom + Zoom - Block Traded | |
|
HANSOH PHARMA Hyped Up 7% as 2025 NP Surges 27%; BOCI Lifts TP to HKD43.5
2026-03-31 14:19:10 HANSOH PHARMA (03692.HK) opened flat today and once peaked at HKD35.94. It last traded at HKD35.5, up 7.32%, with a volume of 12.3003 million shares, involving HKD431 million. The company's turnover grew by 22.6% YoY to RMB15.028 billion in 2025, while net profit rose by 27.1% YoY to RMB5.555 billion, with EPS at RMB0.93. BOCI said in its research report that HANSOH PHARMA has successfully transformed itself into an innovation-oriented pharma company, as evidenced by its strong results for 2025. The broker has reiterated a Buy rating on the drug maker and raised its target price from HKD41.3 to HKD43.5. ~ AAStocks Financial News Web Site: www.aastocks.com | |